Bio
I work as a Senior Director of Finance, working as the Finance Business Partner to the President of the Commercialisation & Outcomes service area (ICO), as well as to the President of the Analytics & Consulting (A&C) service area within ICON. I’ve been with ICON for over six years, having worked as a Controller before becoming Senior Director. I have over 20 years’ experience within finance and auditing and joined ICON back in 2008. In that time I’ve experienced some great development opportunities, including a course called 7 Habits of Highly Effective People, as well as a University College Dublin (UCD) International Business Management course in 2014. I’ve risen from Controller for Early Phase (US) to Global Controller for Early Phase (US and UK), before becoming the Senior Director in Business Planning.
In that time, I’ve witnessed the rapid growth of the company and have worked with a number of fantastic teams throughout the organisation. The growth of ICON has meant that my work is always changing, bringing new challenges – it keeps my line of work highly stimulating and has been great for my own development. I enjoy working for a company whose aim is the betterment of people’s lives – it adds that little bit extra motivation to everything I do!
Latest jobs
Life at ICON
.png)
Teaser label
IndustryContent type
BlogsPublish date
07/21/2025
Summary
What is Real World Evidence? Understanding its Role in Clinical Research Real World Evidence (RWE) is a term increasingly being used within the healthcare and pharmaceutical industries, shaping cr
.png)
Teaser label
IndustryContent type
BlogsPublish date
07/07/2025
Summary
Precision at the Outset: The Strategic Role of Site Selection and Activation in Clinical Trials The success of any clinical trial begins well before the first patient is enrolled. Behind every sit
.png)
Teaser label
IndustryContent type
BlogsPublish date
07/04/2025
Summary
Cybersecurity in Clinical Data Management In clinical research, data is both a vital asset and a significant responsibility. As trials become increasingly digitised and decentralised, the protectio
Recently viewed jobs